Antiinflammatory and Anticancer Properties of <i>Grewia asiatica</i> Crude Extracts and Fractions: A Bioassay-Guided Approach

Qamar, Muhammad; Akhtar, Saeed; Barnard, Ross T.; Sestili, Piero; Ziora, Zyta M.; Lazarte, Claudia E.; Ismail, Tariq

doi:https://doi.org/10.1155/2022/2277417

BioMed Research International

On this page

Abstract Introduction Materials and Methods Results and Discussion Conclusion Abbreviations Data Availability Disclosure Conflicts of Interest Supplementary Materials References Copyright Related Articles

Special Issue

Plant-Derived Anticancer Agents as an Option for Cancer Treatment 2021

View this Special Issue

Research Article | Open Access

Volume 2022 | Article ID 2277417 | https://doi.org/10.1155/2022/2277417

Antiinflammatory and Anticancer Properties of Grewia asiatica Crude Extracts and Fractions: A Bioassay-Guided Approach

Muhammad Qamar,¹Saeed Akhtar,¹Ross T. Barnard,²Piero Sestili,³Zyta M. Ziora,⁴Claudia E. Lazarte,⁵and Tariq Ismail^1,5

Academic Editor: Yearul Kabir

Received21 Oct 2021

Revised04 Mar 2022

Accepted09 Mar 2022

Published28 Mar 2022

Abstract

The study was an extension of our earlier work on antiinflammatory and anticancer properties of G. asiatica fruit. We aimed to develop a bioassay guided multistep purification technique for producing bioactive fractions of G. asiatica crude extracts. Dried fruit powder was sequentially fractionated with 100% dichloromethane, 100% methanol (MeOH), and 50% MeOH. Active extracts were subjected to liquid-liquid partitioning followed by subfractionation using RP-HPLC. Antioxidant, antiinflammatory, and anticancer activities of the fruit extracts, and their potent fractions were evaluated in vitro, while identification of compounds from the bioactive fractions was performed by ESI-MS/MS analysis. The amount of the identified compounds present was confirmed using external standards adopting a simple, accurate, and rapid analytical HPLC method. The results showed that 100% and 50% MeOH extracts possessed bioactivity; one of which (the 50% MeOH extract) displayed potent activity in all in vitro bioassays. MeOH extract (50%) derived fraction C and hydroalcoholic fraction 5 (GAHAF5) were observed to possess higher antioxidant, antiinflammatory, and in vitro anticancer activity. IC₅₀ of GAHAF5 against MCF-7, HEp-2, and NCI-H522 cancer cells was recorded as 26.2, 51.4, and 63 μg/mL, respectively. ESI-MS/MS and HPLC analysis identified catechin, chlorogenic acid, caffeic acid, and morin as potential bioactive compounds in the GAHAF5 fraction with concentrations of 1230, 491, 957, and 130 μg/g, respectively. The findings indicated that G. asiatica bioactive fractions possessed antiinflammatory activity in vitro and were cytotoxic against breast cancer, lung cancer, and laryngeal cancer cell lines.

1. Introduction

Worldwide, an increasing rate of mortality linked to cardiovascular complications, diabetes, various forms of cancer, and many other physiological ailments is creating a burden on the healthcare systems. A plethora of literature correlate modifiable lifestyle factors or health behaviors, for example, poor dietary choices, tobacco use, excessive intake of alcohol, and physical inactivity, with an increasing incidence of the aforementioned chronic diseases [1, 2]. Such a situation calls for a paradigm shift in approaches to improving the health of individuals and hence populations [3]. Fruits and vegetables contain nutrient and nonnutrient substances bearing medicinal properties and are traditionally widely accepted for their relevance to the prevention of various health ailments. However, uncertainties in links between consumption of fruits and vegetables and the reduction of risk of chronic disease require the systematic establishment of a clear connection between the nutrient or nonnutrient components and their ability to reduce the risk of disease [4].

Cancer is among the most common of life-threatening diseases. The International Agency for Research on Cancer has reported worldwide an estimation of 19.3 million new cancer cases and almost 10.0 million cancer-related deaths in the year 2020 [5]. According to the Global Cancer Statistics, Asia has the highest share of cancer-related deaths (57.3%). Approximately one-half of all new cancer cases and more than one-half of the overall cancer deaths were reported from Asia. With an estimation of 2.26 million new cases, breast cancer was reported as the leading type of cancers diagnosed, while the highest incident of cancer-related mortalities, i.e., 1.79 million, was accounted for lung cancer [5, 6]. Chemotherapy, radiotherapy, and chemical drugs are commonly utilized cancer therapies; however, the cost of treatment is high, and there are often adverse side effects [7, 8]. For these reasons, plant-based new medicines are being increasingly investigated as possible alternatives to synthetic drugs subject to their efficacy and consumers’ safety [9].

More than 60% of anticancer drugs including vinblastine, vincristine, camptothecin, taxol, podophyllotoxin, and combretastatin are reported to be retrieved from natural sources [10]. The importance of plants and fungi is illustrated by the discovery of penicillin, morphine, and aspirin, the semisynthetic acetylated derivatives of natural salicylic acid. Penicillin is an antibiotic, morphine is a pain reliever, and aspirin is a cyclooxygenase inhibitor used as an antipain, antifever, and antiinflammatory drug, as well as in the prevention of strokes and heart attack owing to its antiplatelet potential [11, 12]. However, many plants used in conventional medicinal or healthcare systems still require scientific exploration and validation.

G. asiatica L. (Tiliaceae), a berry indigenously known as Phalsa, is endemic to South Asian countries, mainly Pakistan and India [1]. Ethnic or traditional use of G. asiatica fruit is predominantly used as a refreshing, thirst quenching drink in summer. The fruit drink, also known in some countries as “phalsay ka sharbat,” is thought to be tonic, while the fruit and bark infusions of G. asiatica are considered demulcent, febrifuge, and diarrheal remedies [12]. The traditional medicinal claims of G. asiatica and its secondary metabolites like flavonoids, phenolic acids, and anthocyanins are supported by the documented pharmacological activities, including antiinflammatory, antidiabetic, anticancer, skin health promotive, and reduction of risk of coronary heart disease [13–16].

In an extension of our earlier work “anticancer and anti-inflammatory perspectives of Pakistan’s indigenous berry Grewia asiatica Linn (Phalsa)” [16], there was a need to identify bioactive fractions of G. asiatica as a prelude to their potential exploitation in the food and pharmaceutical industry. This study was therefore intended to develop a bioassay-guided sequential extraction method for recovering bioactive rich fractions of G. asiatica fruit and to isolate fractions that may possess higher free radical scavenging, antiinflammatory, and in vitro cytotoxic activities against human cancer cells.

2. Materials and Methods

2.1. Plant Material

Grewia asiatica fruits known in Pakistan as Phalsa were supplied by a local grower (Multan, Punjab, Pakistan), and taxonomic identification was performed by a botanical expert from the Department of Botany, Bahauddin Zakariya University, Multan. The berries were washed to remove dirt, and then the seed-free pulp was extracted with a fine fruit pulper. The fruit pulp was spread onto stainless steel trays with thickness lesser than 4 mm and dehydrated in a commercial dehydrator (Pamico Tech. Pak) at 40°C. The dehydrated fruit pulp was ground to powder in a kitchen scale grinder and stored in an airtight jar at 4°C for further processing.

2.2. Solvents and Reagents

HPLC grade solvents (water, methanol), antiinflammatory and anticancer standard drugs (diclofenac sodium, methotrexate), and analytical and preparative HPLC columns (Zorbax-SB-C-18, Agilent) were purchased from the local supplier of Sigma-Aldrich, USA. Analytical grade solvents, antioxidant assays’ reagents, and reference standards were procured from Merck, Pakistan.

2.3. Ethical Approval

All studies and testing protocols were in line with the ethical codes mentioned in the Declaration of Helsinki, duly approved by the Bioethical Committee, Bahauddin Zakariya University, Multan, Reg. no. 05-18.

2.4. Preparation of Extracts

The dried fruit powder was delipidated with hexane and filtered through Whatman No. 1 filter paper. Filtration residues were sequentially fractionated with 100% dichloromethane (DCM), 100% methanol (MeOH), and then 50% MeOH (50 : 50 v/v H₂O : MeOH) using an orbital shaker. All filtrates were subjected to rotary evaporation (Heidolph, Germany) and stored in an upright ultralow freezer (Sanyo, Japan) at −40°C for bioactive fraction screening assays. The most potent extracts, as evaluated by performance of bioassays, were subjected to liquid-liquid partitioning by solubilization with water (Fraction C) and then partitioned successively, first with chloroform (Fraction A) and then with ethyl acetate (Fraction B), as illustrated in Figure 1.

2.5. Determination of Antioxidant Activity

2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity of the test samples was conducted in accordance with the method proposed by Alara et al. [17]. The results were calculated as IC₅₀ (μg/mL) and compared with the standards, i.e., ascorbic acid and quercetin.

Similarly, hydrogen peroxide (H₂O₂) scavenging ability assay was performed with the method followed by Ruch et al. [18] with minor changes. Ascorbic acid and quercetin were used as reference standards, and the results are computed using the following equation: where A_o indicates the absorbance measured for control and A_s refers to the sample or standard absorbance.

Ferric reducing antioxidant power (FRAP) assay was also performed in accordance with the method followed by Zahin et al. [19]. Ferrous sulfate was used as a reference standard, and the results were computed as mM Fe/g.

2.6. In Vitro Antiinflammatory Activity Assays

2.6.1. Membrane Stabilization Assay (Heat-Induced Hemolysis)

Blood was collected in heparinized tubes from healthy human subjects from the cubital vein and centrifuged at 1100 × g for 5 minutes. Blood cells were washed three times with normal saline. The volume of blood was measured and reconstituted as 10% v/v suspension with isotonic buffer solution (10 mM sodium phosphate buffer, pH 7.4) [20, 21].

The membrane stabilization assay was performed in accordance with the method described by Shinde et al. [22]. Briefly, a reaction mixture (2 mL) was prepared by adding 1 mL experimental extracts of different strengths, i.e., 50, 100, 200, and 300 μg/mL to 1 mL (10%) red blood cell (RBC) suspension in isotonic buffer solution (pH 7.4). The tubes containing the reaction mixture were incubated (25 min; 50°C) and cooled. The reaction mixture was centrifuged (1100 × g; 3 min), and the absorbance of the supernatant was checked at 560 nm using a spectrophotometer. Diclofenac sodium was used as a positive control while phosphate buffer as a negative control. The inhibition rate is calculated in accordance with the following equation:

2.6.2. Egg Albumin Denaturation Assay

Egg albumin denaturation assay was performed by the method described by Mizushima and Kobayashi [23]. Briefly, 5 mL of the reaction mixture was prepared by mixing egg albumin (0.2 mL), 2.8 mL phosphate buffer (pH 6.5), saline, and 2 mL of extracts of different concentrations, i.e., 50, 100, 200, and 300 μg/mL. The reaction mixture was incubated for a period of 20 min at 40°C followed by heating at 75°C for 5 min in a water bath. The contents of the tubes were cooled, and the absorbance was read spectrophotometrically at 660 nm. Diclofenac sodium and phosphate buffer solution were used as positive and negative control, respectively. Inhibition rates (%) are derived from the following equation:

2.6.3. Bovine Serum Albumin Denaturation Assay

Bovine serum albumin denaturation assay was performed in accordance with the method followed by Sakat et al. [21]. Reaction mixture (0.5 mL) was made by adding 0.45 mL of bovine serum albumin and 0.05 mL of experimental extracts of different strengths (50-300 μg/mL). Phosphate buffer (2.5 mL; pH 6.3) was mixed with the reaction mixture, and the contents of the test tubes were incubated for 25 min at 40°C. Cooling was performed, and absorbance was recorded with UV-Vis spectrophotometer (660 nm). Diclofenac sodium and phosphate buffer solution were used as positive and negative controls, respectively. The percent inhibition rates are calculated using the following equation:

2.7. In Vitro Anticancer Activity

2.7.1. Methyl Thiazolyl Tetrazolium (MTT) Assay

G. asiatica extracts and their fractions were evaluated for in vitro anticancer potential with the method utilized by Roy et al. [24]. Experimental samples of varying strengths (0.5–200 μg/mL) were prepared in 100 μL dimethylsulphoxide (1% v/v) in microtiter plates. After incubating the microtiter plates (37°C, 48 hours), to each well was added 50 μl of the MTT solution (5 mg/mL). A microplate reader (Tecan, Austria) was used to check the reduction in MTT after a second incubation (37°C, 4 hours) by recording the absorbance at 570 nm. The untreated cells were used as a control against which to measure the effect of experimental extracts on the cell viability. The percent inhibition exhibited on the cell cultures by the test samples is computed using the following equation: where At, Ab, and Ac indicate the sample, blank (complete media without cells), and control absorbance, respectively.

2.8. Method Optimization for Fractionation Using RP-HPLC

Fraction C (50% MeOH extract) and Fraction B (100% MeOH extract) were further fractionated using RP-HPLC by dissolving solidified fractions in MeOH (100%) as suggested by Cock [25]. Method optimization for fractionation was performed through Agilent LC technology using an SB-C-18 analytical column (4.6 × 150 mm, 5 μm, Agilent, Germany). The sample was prepared in MeOH at the concentration of 10 mg/mL, and the contents were filtered using 0.45 μm syringe filter. The sample injection limit was set at 5 μL with a flow rate of 0.5 mL/min. Maximum peaks were recorded with acidified (0.1% TFA) water (A) and acidified (0.1% TFA) methanol (B) at 210 (Fraction C) and 280 nm (Fraction B).

2.9. RP-HPLC Fractionation (Reverse Phase Chromatography)

RP-HPLC fractionation was performed using Zorbax SB-C18 semipreparative column (25 × 250 mm, 5 μm particle size, Agilent, Germany). The samples were prepared in 100% MeOH as 50 mg/mL; the injection limit was set as 1 mL with a flow rate of 10 mL/min. Eight subfractions were obtained from Fraction C (50% MeOH extract) named G. asiatica hydroalcoholic extracts, fractions 1–8, i.e., GAHAF1, GAHAF2, GAHAF3, GAHAF4, GAHAF5, GAHAF6, GAHAF7, and GAHAF8. Accordingly, 5 subfractions were derived from the Fraction B (100% MeOH extracts) termed as G. asiatica methanolic fractions 1–5, i.e., GAMF1, GAMF2, GAMF3, GAMF4, and GAMF5.

2.10. ESI-MS/MS Analysis

HPLC subfractions with potent activities led to LC-ESI-MS/MS (LTQ XL, Thermo Electron Corporation, USA) analysis for identification of bioactive components adapting guidelines as described earlier by Steinmann and Ganzera [26]. The online software (http://www.chemspider.com/) was used to obtain the structural details of the bioactive compounds identified in the present study.

2.11. Quantification Using External Standards

Bioactive compounds tentatively identified earlier were further confirmed by comparing the retention times with external standards and quantified from the percent peak area using HPLC. The chromatograms were obtained at different wavelengths (230, 254, 280, 300, 330 nm). The analytical method for qualitative and quantitative analysis was validated according to the guidelines issued by the proceedings of the International Conference on Harmonization (ICH) for specificity, linearity, accuracy, precision, LOD, and LOQ.

2.12. Statistical Analysis

The data were expressed as . One-way analysis of variance (ANOVA) was used to measure statistical differences between the controls and treatments. The data was subsequently analyzed by Dunnett’s test. Prism (Graph Pad Software, San Diego, USA) was used to plot the graphs, and values were indicated as follows: , , , and .

3. Results and Discussion

3.1. Antioxidant Activity

The results presented in Table 1 show that Fraction C and Fraction B possessed the lowest IC₅₀ in the DPPH assay, the highest ferric reducing antioxidant power (FRAP), and the maximum radical scavenging in H₂O₂ assay compared to their parent extracts, i.e., 50% MeOH and 100% MeOH extract, respectively. Among RP-HPLC subfractions, GAHAF5 of Fraction C (50% MeOH extract) exhibited considerable radical scavenging potential in DPPH (IC₅₀ of 29 μg/mL), FRAP (46 mmol/g), and H₂O₂ (77%) assays, comparable to the antioxidant activity of standard ascorbic acid or quercetin (Table 1). Likewise, a notable increase in the antioxidant activity was also observed for GAMF3 in comparison to Fraction B (100% MeOH extract). Previously, a methanol extract of G. asiatica leaves was reported to hold notable DPPH radical scavenging activity (IC₅₀ of 27.3 pg/mL) and nitric oxide radical inhibition activity (IC₅₀ of 56.85 μg/mL) when compared with ascorbic acid or quercetin as standards [27]. The strong antioxidant potential of G. asiatica was also cited by Mesaik et al. [28], who reported that the 20 ppm flavanol fraction of the fruit produced 85% inhibition of DPPH stable-free radicals. Data on qualitative screening of the G. asiatica extracts (Supplementary Table 1) further suggest the fruit as plausible carrier of secondary metabolites such as flavonoids, phenols, and tannins which may serve as active-free radical inhibitors alike other fruits of ethnomedicinal significance including S. cumini and C. carandas.

3.2. In Vitro Antiinflammatory Activity

3.2.1. Heat-Induced Hemolysis (Membrane Stabilization)

The stabilization effect of a drug on human red blood cell membranes (HRBC) against heat and hypotonicity induced lysis is documented as a proxy for antiinflammatory action of a drug [29, 30]. The human red blood cell membrane and lysosomal membrane are similar in composition; therefore, drugs protecting HRBC membrane may also protect against destruction of the lysosomal membrane [31].

Consistent with the above, antiinflammatory activity of G. asiatica successive extracts, their partitioned fractions, and RP-HPLC subfractions were studied at varying concentrations (50, 100, 200, and 300 μg/mL). The findings revealed a dose-dependent inhibition of heat-induced hemolysis and improved efficacy of the extracts from crude RP–HPLC subfractions. Among the tested fractions, GAHAF5 anticipated 59% inhibition of heat-induced hemolysis at a dose of 300 μg/mL, whilst the inhibition by 50% MeOH extract and fraction C was 50 and 56%, respectively. Data shown in Table 1 suggest a strong relationship between antioxidant and antiinflammatory activity. A similar study conducted by Moussaid et al. [32] reported a positive correlation between the concentrations of experimental extracts and membrane stabilization. Furthermore, extracts having antioxidant activity considerably inhibited the inflammatory responses. Likewise, 100% MeOH extract, Fraction B, and GAMF3 dispensed at 300 μg/mL exerted 32 and 46% inhibition in heat-induced hemolysis when compared with the normal control, respectively. Earlier, Khanal et al. [33] in their study on antiinflammatory activity of G. asiatica fruit extracts—as determined with membrane stabilization assays—reported 81% inhibition at 600 μg/mL, a finding remarkably like ours.

3.2.2. Inhibition of Protein Denaturation (Serum and Egg Albumin)

Denaturation of proteins is a well-documented cause of inflammation, while substantial data is available to confirm the link between denaturation of tissue proteins and the onset of inflammatory complications [34, 35]. Plant extracts, owing to their capacity to react with erythrocyte membrane proteins, may deform the cells [21] and provoke alteration of cell surface charges [36].

Our multistep purification technique produced fractions that positively affected egg albumin denaturation inhibition: indeed, a 56% inhibition of albumin denaturation was observed for crude extracts (50% MeOH extract), and a 63% inhibition was found in the case of the purified successive fraction (GAHAF5). The results further suggested a dose-dependent albumin denaturation inhibitory response that has also been documented for coffee extracts compared with the diclofenac sodium standard [37]. Another study delineated a dose-dependent effect of methanolic extract of Enicostemma axillare with a maximum inhibition of 71% observed at 500 μg/mL [38]. Accordingly, moderate inhibition of protein denaturation at 300 μg/mL was observed with pure MeOH extract (36%), Fraction B (44%), and GAMF3 (51%) (Table 1).

A similar inhibitory trend was recorded against serum albumin denaturation assay suggesting that 50% MeOH extract (300 μg/mL) exhibit the highest inhibition of albumin denaturation, i.e., 65%, when compared to other extracts. Among liquid-liquid partitioned fractions, only Fraction C and, from RP-HPLC subtractions, only GAHAF5 outlined inhibitory activity as 70% and 75%, respectively, in albumin denaturation inhibition assay which is slightly more than the parent 50% MeOH extract. A standard drug, diclofenac sodium, offered a potent inhibition of 98%, 96%, and 98% at a dose of 300 μg/mL against heat-induced hemolysis, egg albumin denaturation, and bovine serum albumin denaturation assays, respectively (Table 1).

3.3. Anticancer Activity

The crude MeOH extracts (50 and 100%) demonstrated potent to moderate in vitro anticancer activity which was further characterized in the successive extracts obtained through bioassay guided fractionation. Bioassay-guided fractionation is an established and effective method for purifying anticancer, antifungal, and antifertility compounds [39–41]. Our results suggest that the 50% MeOH extract derived Fraction C as the fraction exhibiting the highest anticancer activity, with an IC₅₀ of 30 μg/mL, 81 μg/mL, 73 μg/mL, 114 μg/mL, and 279 μg/mL against human cell lines derived from breast cancer, lung cancer, laryngeal cancer, epidermal kidney cancer, and cervical cancer, respectively. Since IC₅₀ of extracts and fractions against epidermal kidney cancer and cervical cancer were above 100 μg/mL, the values are therefore not tabulated. In the case of breast and laryngeal cancer cell lines, Fraction C demonstrated the lowest IC₅₀ when compared with the parent extracts. Similarly, Fraction B originating from 100% MeOH extract exerted considerable cytotoxic activity against breast and lung cancer cell lines. IC₅₀ of fraction B against breast cancer and lung cancer were 61 μg/mL and 95 μg/mL, respectively, which are also higher than recorded from the parent extracts (Table 1).

The IC₅₀ for 50% MeOH extract against MCF-7 breast cancer cells was up to 35 μg/mL, while lower values were recorded for fraction C and subfraction GAHAF5, i.e., 30 μg/mL and 26 μg/mL, respectively. Parallel trends were observed with lung and laryngeal cancer cell lines, where GAHAF5 exhibited the lowest IC₅₀, i.e., 63 μg/mL and 51 μg/mL with lung cancer and laryngeal cancer, respectively. Interestingly, GAMF3 from Fraction B was cytotoxic against the breast cancer cell line (IC₅₀ of 52 μg/mL). Previously, M1 fractions retrieved from the parent hexane extract of Mangifera zeylanica bark obtained through a series of purification techniques were reported more effective than the parent hexane extract against three cancer cell lines. The referenced study demonstrated a less toxic effect of bioassay guided fraction when compared with the parent extracts on normal mammary epithelial cells [41]. Glaucarubinone, a triterpenoid obtained from the hexane extracts of Brazilian cerrado, was reported biologically active against cancer cell lines of common cancers [42].

3.4. ESI-MS/MS Analysis

The bioactive fraction of G. asiatica fruit extracts, i.e., GAHAF5, was identified to contain caffeic acid, morin, catechin, and chlorogenic acid (Figure 2. Table 2). Mass spectras of compounds that we were unable to identify are also available in Supplementary Figures 1 and 2. Previously, all referred compounds have been cited as antiinflammatory agents [43–46]. Morin appeared to induce cytotoxicity among metastatic breast and lung cancer cells [47, 48]. Caffeic acid was reported to induce apoptosis in breast cancer [49] and lung cancer cells [50]. Chlorogenic acid regulated apoptosis in A549 human lung and breast cancer cells [51]. In addition, catechin was reported to exhibit a significant inhibition in the proliferation of breast [52] and lung cancer [53].

Likewise, liquiritigenin, quercetin, and myricetin were also identified in GAMF3 fraction of our study (Figure 2), while the literature confirms the significant antiinflammatory potential of liquiritigenin [54], myricetin [55], and quercetin [56]. Moreover, liquiritigenin, myricetin, and quercetin were also presented as potent breast cancer inhibitors in some previous findings [57–59].

3.5. Quantification of Bioactive Compounds Using External Standards

3.5.1. Specificity Validation

The analytical method was evaluated for its specificity by comparing the retention times and mass spectra of external standards with HPLC chromatogram peaks of G. asiatica fractions. Firstly, a visible separation effect was obtained for catechin, chlorogenic acid, caffeic acid, and morin eluted at 19.3, 20.7, 21.8, and 22.6 minutes, respectively, from standard solution and from GAHAF5 (Figure 3). Likewise, it has been apparent from Figure 4 that well-distinguished peaks of myricetin, quercetin, and liquiritigenin were established and eluted at 24.1 minutes (myricetin), 25.0 minutes (quercetin), and 23.2 minutes (liquiritigenin). Chromatograms of GAMF3 also showed visible peaks of quercetin, liquiritigenin, and myricetin at similar retention times.

(a)

(b)

(a)

(b)

(c)

3.5.2. Quantification Parameters

The current method was validated for linearity performance using calibration curves. Seven calibration curves in triplicate were established. The calibration curves of catechin, chlorogenic acid, caffeic acid, morin, myricetin, quercetin, and liquiritigenin were linear between 46.8 and 1500, 7.8 and 500, 7.8 and 500, 46.8 and 1500, 12.5 and 200, 1.6 and 25, and 3.9 and 250 μg/mL with a regression coefficient (²) between 0.9985 and 0.9995. Regression data, LODs, and LOQs for all seven standard substances are given in Table 3.

3.5.3. Accuracy Validation

Bioactive fractions of G. asiatica, i.e., GAHAF5 and GAMF3, were spiked with standards of varying concentrations, i.e., 200, 400, and 500 μg/mL. Recovery rates of the compounds listed in Table 4 were within the range of - with a percent variation coefficient between 1.02 and 3.65% (Table 4). HPLC overlay chromatograms were also developed to identify the percentage recovery of the bioactive compounds of G. asiatica. Figures 5 and 6 represent overlay chromatograms of G. asiatica 50% MeOH extract, Fraction C with standard chlorogenic acid (1 : 1), and 100% MeOH derived Fraction B with standard liquiritigenin (1 : 1), respectively.

3.5.4. Precision Validation

Instrumental precision was determined by replicate analysis of external standards. The results of intraday and interday analysis of all seven standard compounds showed a high precision with coefficient of variation below 2%, which demonstrates the good precision of our analytical investigation (Table 5).

3.5.5. Quantification Analysis

In this study, the chromatogram peak heights of both fractions (GAHAF5, GAMF3) were compared with those of external standards. The peak height with similar retention times indicates the presence of the respective compounds whose levels were quantified using calibration curves obtained with the corresponding external standards. The detected levels of catechin, chlorogenic acid, caffeic acid, and morin in GAHAF5 were 1230, 491, 957, and 130 μg/g, respectively. Likewise, the levels of liquiritigenin, quercetin, and myricetin in GAMF3 were 217, 591, and 24 μg/g. Earlier, quercetin was detected as 2.4 ng/μl and 4.28 ng/μl in G. asiatica callus and leaf extracts, respectively [60]. More recently, LC-QToF-MS analysis of G. asiatica extracts tentatively identified and provided relative abundance of some bioactive compounds like quercetin, myricetin, umbelliferone, isovitexin, petunidin, kaempferol, and morin as 0.44, 4.87, 0.10, 0.33, 0.60, 0.87, and 4.25 μg/g, respectively [61].

4. Conclusion

Bioassay-guided fractionation of G. asiatica fruit extracts proved to be promising as a means to obtain bioactive fractions bearing significant in vitro antioxidant, antiinflammatory, and in vitro anticancer activity. Bioactive compound characterization data suggest that chlorogenic acid, caffeic acid, gallic acid, and morin represent the key components of GAHAF5 responsible for the cytotoxic effect on breast, lung, and laryngeal cancer cells. Bioactive fractions from the G. asiatica fruit extracts as recovered in this study are potential drug leads and warrant additional testing and determination of therapeutic index in vivo.

Abbreviations

RP-HPLC:	Reverse phase high performance liquid chromatography
ESI-MS/MS:	Electrospray ionization mass spectrometry
MCF-7:	Breast cancer cell line
HEp-2:	Laryngeal cancer cells
NCI-H522:	Lung cancer cell line
DPPH:	2,2-diphenyl-1-picrylhydrazyl
FRAP:	Ferric reducing antioxidant power
H₂O₂:	Hydrogen peroxide
MTT:	Methyl thiazolyl tetrazolium
GAMF:	Grewia asiatica methanolic fraction
GAHAF5:	Grewia asiatica hydroalcoholic fraction
100% MeOH:	100% methanolic extract
50/50 H₂O:	MeOH 50% hydromethanolic extract
TFA:	Triflouroacetic acid
LOD:	Limit of detection
LOQ:	Limit of quantification
²:	Regression coefficient
Rt min:	Retention time in minutes.

Data Availability

The data supporting the conclusion of this study are included and are available within the article.

Disclosure

The data presented in this manuscript is a part of the doctoral thesis of Mr. Muhammad Qamar, Institute of Food Science & Nutrition, Bahauddin Zakariya University, Multan, Pakistan.

Conflicts of Interest

The authors declare no conflicts of interest.

Supplementary Materials

Supplementary Figures 1 and 2: raw data of ES-MS/MS analysis of GAHAF5 and GAMF3 fractions showing spectras of known and unknown compounds. Supplementary Table 1: qualitative screening of G. asiatica fruit extracts showing presence of secondary plant metabolites. (Supplementary Materials)

References

M. Fortin, J. Haggerty, J. Almirall, T. Bouhali, M. Sasseville, and M. Lemieux, “Lifestyle factors and multimorbidity: a cross sectional study,” BMC Public Health, vol. 14, no. 1, pp. 1–8, 2014.
View at: Publisher Site | Google Scholar
A. Alwan, Global status report on noncommunicable diseases 2010, World Health Organization, Geneva, 2011.
J. Wardle and E. B. Oberg, “The intersecting paradigms of naturopathic medicine and public health: opportunities for naturopathic medicine,” The Journal of Alternative and Complementary Medicine, vol. 17, no. 11, pp. 1079–1084, 2011.
View at: Publisher Site | Google Scholar
H. Boeing, A. Bechthold, A. Bub et al., “Critical review: vegetables and fruit in the prevention of chronic diseases,” European Journal of Nutrition, vol. 51, no. 6, pp. 637–663, 2012.
View at: Publisher Site | Google Scholar
H. Sung, J. Ferlay, R. L. Siegel et al., “Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries,” CA: A Cancer Journal for Clinicians, vol. 71, no. 3, pp. 209–249, 2021.
View at: Publisher Site | Google Scholar
F. Bray, J. Ferlay, I. Soerjomataram, R. L. Siegel, L. A. Torre, and A. Jemal, “Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries,” CA: A Cancer Journal for Clinicians, vol. 68, no. 6, pp. 394–424, 2018.
View at: Publisher Site | Google Scholar
M. S. Khan, F. A. Qais, and I. Ahmad, “Indian berries and their active compounds: therapeutic potential in cancer prevention,” New Look to Phytomedicine, Academic Press, United Kingdom, pp. 179–201, 2019.
View at: Google Scholar
V. Charepalli, L. Reddivari, R. Vadde, S. Walia, S. Radhakrishnan, and J. K. Vanamala, “Eugenia jambolana (Java plum) fruit extract exhibits anti-cancer activity against early stage human HCT-116 colon cancer cells and colon cancer stem cells,” Cancers, vol. 8, no. 3, p. 29, 2016.
View at: Publisher Site | Google Scholar
U. Shah, R. Shah, S. Acharya, and N. Acharya, “Novel anticancer agents from plant sources,” Chinese Journal of Natural Medicines, vol. 11, no. 1, pp. 16–23, 2013.
View at: Publisher Site | Google Scholar
G. M. Cragg and D. J. Newman, “Plants as a source of anti-cancer agents,” Journal of Ethnopharmacology, vol. 100, no. 1-2, pp. 72–79, 2005.
View at: Publisher Site | Google Scholar
G. Samuelsson, Drugs of Natural Origin: A Textbook of Pharmacognosy, Swedish Pharmaceutical Press, Stockholm Sweden, 2004.
A. K. Yadav, “Phalsa: a potential new small fruit for Georgia,” Perspectives on new crops and new uses, ASHS Press, Alexandria, VA, United States, pp. 348–352, 1999.
View at: Google Scholar
M. S. Butler, “The role of natural product chemistry in drug discovery,” Journal of Natural Products, vol. 67, no. 12, pp. 2141–2153, 2004.
View at: Publisher Site | Google Scholar
Choudhary et al., “U.S. Patent and Trademark Office,” U.S. Patent No. 10,005,809, 2018.
View at: Google Scholar
R. Shukla, D. C. Sharma, N. Pathak, and P. Bajpai, “Genomic DNA isolation from high polyphenolic content Grewia asiatica L. leaf without using liquid nitrogen,” Science, vol. 42, no. 2, pp. 347–351, 2018.
View at: Publisher Site | Google Scholar
M. Qamar, S. Akhtar, T. Ismail, P. Sestili, A. Tawab, and N. Ahmed, “Anticancer and anti-inflammatory perspectives of Pakistan’s indigenous berry Grewia asiatica Linn (phalsa),” Journal of Berry Research, vol. 10, no. 1, pp. 115–131, 2020.
View at: Publisher Site | Google Scholar
O. R. Alara, N. H. Abdurahman, S. A. Mudalip, and O. A. Olalere, “Effect of drying methods on the free radicals scavenging activity of _Vernonia amygdalina_ growing in Malaysia,” Journal of King Saud University-Science, vol. 31, no. 4, pp. 495–499, 2019.
View at: Publisher Site | Google Scholar
R. J. Ruch, S. J. Cheng, and J. E. Klaunig, “Prevention of cytotoxicity and inhibition of intercellular communication by antioxidant catechins isolated from Chinese green tea,” Carcinogenesis, vol. 10, no. 6, pp. 1003–1008, 1989.
View at: Publisher Site | Google Scholar
M. Zahin, F. Aqil, and I. Ahmad, “Broad spectrum antimutagenic activity of antioxidant active fraction of _Punica granatum_ L. peel extracts,” Mutagenesis, vol. 703, no. 2, pp. 99–107, 2010.
View at: Publisher Site | Google Scholar
J. Sadique, W. A. Al-Rqobahs, E. I. Bughaith, and A. R. Gindi, “The bioactivity of certain medicinal plants on the stabilization of RBC membrane system,” Fitoterapia, vol. 60, no. 6, pp. 525–532, 1989.
View at: Google Scholar
S. Sakat, A. R. Juvekar, and M. N. Gambhire, “In vitro antioxidant and anti-inflammatory activity of methanol extract of Oxalis corniculata Linn,” International Journal of Pharmacy and Pharmaceutical Sciences, vol. 2, no. 1, pp. 146–155, 2010.
View at: Google Scholar
U. A. Shinde, A. S. Phadke, A. M. Nair, A. A. Mungantiwar, V. J. Dikshit, and M. N. Saraf, “Membrane stabilizing activity -- a possible mechanism of action for the anti- inflammatory activity of _Cedrus deodara_ wood oil,” Fitoterapia, vol. 70, no. 3, pp. 251–257, 1999.
View at: Publisher Site | Google Scholar
Y. Mizushima and M. Kobayashi, “Interaction of anti-inflammatory drugs with serum proteins, especially with some biologically active proteins,” Journal of Pharmacy and Pharmacology, vol. 20, no. 3, pp. 169–173, 1968.
View at: Google Scholar
M. Roy, S. Chakraborty, M. Siddiqi, and R. K. Bhattacharya, “Induction of apoptosis in tumor cells by natural phenolic compounds,” Asian Pacific Journal of Cancer Prevention, vol. 3, no. 1, pp. 61–67, 2002.
View at: Google Scholar
I. E. Cock, “Problems of reproducibility and efficacy of bioassays using crude extracts, with reference to Aloe vera,” Pharmacognosy Communication, vol. 1, no. 1, pp. 52–62, 2011.
View at: Publisher Site | Google Scholar
D. Steinmann and M. Ganzera, “Recent advances on HPLC/MS in medicinal plant analysis,” Journal of Pharmaceutical and Biomedical Analysis, vol. 55, no. 4, pp. 744–757, 2011.
View at: Publisher Site | Google Scholar
M. K. Gupta, R. Lagarkha, D. K. Sharma, P. K. Sharma, R. Singh, and H. S. Ansari, “Antioxidant activity of the successive extracts of Grewia asiatica leaves,” Asian Journal of Chemistry, vol. 19, no. 5, p. 3417, 2007.
View at: Google Scholar
M. A. Mesaik, A. Ahmed, A. S. Khalid et al., “Effect of Grewia asiatica fruit on glycemic index and phagocytosis tested in healthy human subjects,” Pakistan Journal of Pharmaceutical Sciences, vol. 26, no. 1, pp. 85–89, 2013.
View at: Google Scholar
C. S. Kumari, N. Yasmin, M. R. Hussain, and M. Babuselvam, “Invitro anti-inflammatory and anti-artheritic property of rhizopora mucronata leaves,” International Journal of Pharma Sciences and Research, vol. 6, no. 3, pp. 482–485, 2015.
View at: Google Scholar
S. Yesmin, A. Paul, T. Naz et al., “Membrane stabilization as a mechanism of the anti-inflammatory activity of ethanolic root extract of Choi (Piper chaba),” Clinical Phytoscience, vol. 6, no. 1, pp. 1–10, 2020.
View at: Publisher Site | Google Scholar
V. C. Scanlon and T. Sanders, Essentials of Anatomy and Physiology, FA Davis, Philadelphia, PA 19103, United States, 2018.
M. Moussaid, A. E. Elamrani, N. Bourhim, and M. Benaissa, “In vivo anti-inflammatory and in vitro antioxidant activities of Moroccan medicinal plants,” Natural Product Communications, vol. 6, no. 10, pp. 1441–1444, 2011.
View at: Publisher Site | Google Scholar
D. P. Khanal, B. Raut, and M. Kafle, “A comparative study on phytochemical and biological activities of two Grewia species,” Journal of Manmohan Memorial Institute of Health Sciences, vol. 2, pp. 53–60, 2016.
View at: Publisher Site | Google Scholar
E. L. Opie, “On the relation of necrosis and inflammation to denaturation of proteins,” The Journal of Experimental Medicine, vol. 115, no. 3, pp. 597–608, 1962.
View at: Publisher Site | Google Scholar
L. A. D. Williams, A. O'connar, L. Latore et al., “The in vitro anti-denaturation effects induced by natural products and non-steroidal compounds in heat treated (immunogenic) bovine serum albumin is proposed as a screening assay for the detection of anti-inflammatory compounds, without the use of animals, in the early stages of the drug discovery process,” West Indian Medical Journal, vol. 57, no. 4, pp. 327–331, 2008.
View at: Google Scholar
O. O. Oyedapo, B. A. Akinpelu, and S. O. Orefuwa, “Anti-inflammatory effect of Theobroma cacao, root extract,” Journal of Tropical Medicinal Plants, vol. 5, no. 2, pp. 161–166, 2004.
View at: Google Scholar
S. Chandra, P. Chatterjee, P. Dey, and S. Bhattacharya, “Evaluation of _in vitro_ anti-inflammatory activity of coffee against the denaturation of protein,” Asian Pacific Journal of Tropical Biomedicine, vol. 2, no. 1, pp. S178–S180, 2012.
View at: Publisher Site | Google Scholar
G. Leelaprakash and S. M. Dass, “Invitro anti-inflammatory activity of methanol extract of Enicostemma axillare,” International Journal of Drug Development and Research, vol. 3, no. 3, pp. 189–196, 2011.
View at: Google Scholar
A. Malheiros, V. Cechinel Filho, C. B. Schmitt et al., “Antifungal activity of drimane sesquiterpenes from Drimys brasiliensis using bioassay-guided fractionation,” Journal of Pharmaceutical Sciences, vol. 8, no. 2, pp. 335–339, 2005.
View at: Google Scholar
X. Zhang, F. Han, P. Gao, D. Yu, and S. Liu, “Bioassay-guided fractionation of antifertility components of castor bean (Ricinus communis L.) seed extracts,” Natural Product Research, vol. 21, no. 11, pp. 982–989, 2007.
View at: Publisher Site | Google Scholar
M. K. Ediriweera, K. H. Tennekoon, S. R. Samarakoon, I. Thabrew, and E. Dilip De Silva, “A study of the potential anticancer activity of Mangifera zeylanica bark: evaluation of cytotoxic and apoptotic effects of the hexane extract and bioassay-guided fractionation to identify phytochemical constituents,” Oncology Letters, vol. 11, no. 2, pp. 1335–1344, 2016.
View at: Publisher Site | Google Scholar
M. L. de Mesquita, J. E. de Paula, C. Pessoa et al., “Cytotoxic activity of Brazilian Cerrado plants used in traditional medicine against cancer cell lines,” Journal of Ethnopharmacology, vol. 123, no. 3, pp. 439–445, 2009.
View at: Publisher Site | Google Scholar
J. Wang, C. Guo, Z. Wei et al., “Morin suppresses inflammatory cytokine expression by downregulation of nuclear factor-κB and mitogen-activated protein kinase (MAPK) signaling pathways in lipopolysaccharide-stimulated primary bovine mammary epithelial cells,” Journal of Dairy Science, vol. 99, no. 4, pp. 3016–3022, 2016.
View at: Publisher Site | Google Scholar
C. Y. Chao, M. C. Mong, K. C. Chan, and M. C. Yin, “Anti-glycative and anti-inflammatory effects of caffeic acid and ellagic acid in kidney of diabetic mice,” Molecular Nutrition & Food Research, vol. 54, no. 3, pp. 388–395, 2010.
View at: Publisher Site | Google Scholar
N. Yun, J. W. Kang, and S. M. Lee, “Protective effects of chlorogenic acid against ischemia/reperfusion injury in rat liver: molecular evidence of its antioxidant and anti-inflammatory properties,” The Journal of Nutritional Biochemistry, vol. 23, no. 10, pp. 1249–1255, 2012.
View at: Publisher Site | Google Scholar
T. A. Abd El-Aziz, R. H. Mohamed, H. F. Pasha, and H. R. Abdel-Aziz, “Catechin protects against oxidative stress and inflammatory-mediated cardiotoxicity in adriamycin-treated rats,” Clinical and Experimental Medicine, vol. 12, no. 4, pp. 233–240, 2012.
View at: Publisher Site | Google Scholar
H. Jin, W. S. Lee, S. Y. Eun et al., “Morin, a flavonoid from Moraceae, suppresses growth and invasion of the highly metastatic breast cancer cell line MDA-MB-231 partly through suppression of the Akt pathway,” International Journal of Oncology, vol. 45, no. 4, pp. 1629–1637, 2014.
View at: Publisher Site | Google Scholar
D. Yao, H. Cui, S. Zhou, and L. Guo, “Morin inhibited lung cancer cells viability, growth, and migration by suppressing miR-135b and inducing its target CCNG2,” Tumor Biology, vol. 39, no. 10, p. 9, 2017.
View at: Publisher Site | Google Scholar
A. H. Rosendahl, C. M. Perks, L. Zeng et al., “Caffeine and caffeic acid inhibit growth and modify estrogen receptor and insulin-like growth factor I receptor levels in human breast cancer,” Clinical Cancer Research, vol. 21, no. 8, pp. 1877–1887, 2015.
View at: Publisher Site | Google Scholar
C. L. Lin, R. F. Chen, J. Y. F. Chen et al., “Protective effect of caffeic acid on paclitaxel induced anti-proliferation and apoptosis of lung cancer cells involves NF-κB pathway,” International Journal of Molecular Sciences, vol. 13, no. 5, pp. 6236–6245, 2012.
View at: Publisher Site | Google Scholar
K. Yamagata, Y. Izawa, D. Onodera, and M. Tagami, “Chlorogenic acid regulates apoptosis and stem cell marker-related gene expression in A549 human lung cancer cells,” Molecular and Cellular Biochemistry, vol. 441, no. 1-2, pp. 9–19, 2018.
View at: Publisher Site | Google Scholar
L. P. Xiang, A. Wang, J. H. Ye et al., “Suppressive effects of tea catechins on breast cancer,” Nutrients, vol. 8, no. 8, p. 458, 2016.
View at: Publisher Site | Google Scholar
Z. Zhong, Z. Dong, L. Yang, X. Chen, and Z. Gong, “Inhibition of proliferation of human lung cancer cells by green tea catechins is mediated by upregulation of let-7,” Experimental and Therapeutic Medicine, vol. 4, no. 2, pp. 267–272, 2012.
View at: Publisher Site | Google Scholar
Y. W. Kim, R. J. Zhao, S. J. Park et al., “Anti-inflammatory effects of liquiritigenin as a consequence of the inhibition of NF-κB-dependent iNOS and proinflammatory cytokines production,” British Journal of Pharmacology, vol. 154, no. 1, pp. 165–173, 2008.
View at: Publisher Site | Google Scholar
S. J. Wang, Y. Tong, S. Lu et al., “Anti-inflammatory activity of myricetin isolated from Myrica rubra Sieb. et Zucc. leaves,” Planta Medica, vol. 76, no. 14, pp. 1492–1496, 2010.
View at: Publisher Site | Google Scholar
K. Morikawa, M. Nonaka, M. Narahara et al., “Inhibitory effect of quercetin on carrageenan-induced inflammation in rats,” Life Sciences, vol. 74, no. 6, pp. 709–721, 2003.
View at: Publisher Site | Google Scholar
C. Samayoa, A. Kotha, N. K. Krishnegowda, R. K. Vadlamudi, and R. R. Tekmal, “The estrogen receptor β agonists, liquiritigenin and S-equol, inhibit breast cancer cell proliferation through the activation of tumor-suppressor and other pathways,” Cancer Research, vol. 73, Supplement 8, pp. 1312–1312, 2013.
View at: Publisher Site | Google Scholar
D. Jiao and X. D. Zhang, “Myricetin suppresses p21-activated kinase 1 in human breast cancer MCF-7 cells through downstream signaling of the β-catenin pathway,” Oncology Reports, vol. 36, no. 1, pp. 342–348, 2016.
View at: Publisher Site | Google Scholar
J. Duo, G. G. Ying, G. W. Wang, and L. Zhang, “Quercetin inhibits human breast cancer cell proliferation and induces apoptosis via Bcl-2 and Bax regulation,” Molecular Medicine Reports, vol. 5, no. 6, pp. 1453–1456, 2012.
View at: Publisher Site | Google Scholar
N. I. Sharma and V. I. Patni, “Comparative analysis of total flavonoids, quercetin content and antioxidant activity of in vivo and in vitro plant parts of Grewia asiatica mast,” International Journal of Pharmacy and Pharmaceutical Sciences, vol. 5, no. 2, pp. 464–469, 2013.
View at: Google Scholar
T. K. Koley, Z. Khan, D. Oulkar, B. Singh, B. P. Bhatt, and K. Banerjee, “Profiling of polyphenols in phalsa (Grewia asiatica L) fruits based on liquid chromatography high resolution mass spectrometry,” Journal of Food Science and Technology, vol. 57, no. 2, pp. 606–616, 2020.
View at: Publisher Site | Google Scholar
M. Riaz, N. Rasool, M. Iqbal et al., “Liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS) analysis of Russelia equisetiformis extract,” Bulgarian Chemical Communications, vol. 49, no. 2, pp. 354–359, 2017.
View at: Google Scholar
H. Rahman, I. Khan, A. Hussain et al., “Glycyrrhiza glabra HPLC fractions: identification of Aldehydo Isoophiopogonone and Liquirtigenin having activity against multidrug resistant bacteria,” BMC Complementary and Alternative Medicine, vol. 18, no. 1, pp. 1–6, 2018.
View at: Publisher Site | Google Scholar
P. J. Gates and N. P. Lopes, “Characterisation of flavonoid aglycones by negative ion chip-based nanospray tandem mass spectrometry. International journal of analytical chemistry,” vol. 2012, Article ID 259217, p. 7, 2012.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2022 Muhammad Qamar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

1031

Downloads

864

Citations